MHC ligands and peptide motifs: first listingHans‐Georg Rammensee, Stefan Stevanović|Immunogenetics|1995Cited by 1.6k
Biosynthesis of the lantibiotic Pep5Hans-Peter Weil, Hans‐Georg SAHL, Annette G. Beck‐Sickinger et al.|European Journal of Biochemistry|1990Cited by 106
ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMASMichael Platten, Wolfgang Wick, Irini Karapanagiotou‐Schenkel et al.|Neuro-Oncology|2018Cited by 26
A mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group (NOA-16).Michael Platten, Wolfgang Wick, Daniela Schilling et al.|Journal of Clinical Oncology|2018Cited by 25